𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder

✍ Scribed by P. Lemoine; C. Mirabaud

Publisher
Springer
Year
1992
Tongue
English
Weight
134 KB
Volume
106
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind dose-finding study of rol
A double-blind dose-finding study of rolipram in patients with major depressive disorder
✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 460 KB πŸ‘ 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re

A sequential double-blind controlled stu
A sequential double-blind controlled study of moclobemide and mianserin in elderly depressed patients
✍ John Tiller; Dr Kay Maguire; Brian Davies πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

Moclobemide was compared with mianserin in a double-blind controlled study in elderly depressed patients. Sequential analysis of 1 1 pairs of patients found no significant difference between the drugs at the week 8 analysis. Unpaired comparison of the 26 patients completing four weeks' treatment als

Is viloxazine an antidepressant? A place
Is viloxazine an antidepressant? A placebo-controlled double-blind study in major depressive disorder presenting in a general hospital
✍ C. Thompson; G. Isaacs πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 596 KB

## Abstract Viloxazine was one of the first of the β€˜second‐generation’ antidepressants. Its relative lack of cardiotoxic, anticholinergic, sedative and seizure‐inducing adverse effects suggested its use as an antidepressant in general hospitals where tricyclic antidepressants might be frequently co

Fluvoxamine versus fluoxetine in major d
Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison
✍ Jean Dalery; Adriaan Honig πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and